Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Development of composition and technology of the new anti-ischemic drug product
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: TESLEV, Andrey (Saint Petersburg State Chemical-Pharmaceutical Academy, Center of Pharmaceutical Technology, Saint Petersburg, Russian Federation)
- Co-author(s): Andrey Teslev: Center of Pharmaceutical Technology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation
Dmitriy Ivkin: Center of Experimental Pharmacology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation
BackgroundsIschemic heart disease and its acute forms - myocardial infarction and unstable angina - are widespread nowadays and are characterised by a high risk of death.
AimsDevelopment of formulation, technological approaches and quality control techniques for film-coated tablets of 4-(3-ethoxy-3-oxopropanamido)benzoic acid
MethodsPhysical,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019